SCHEMBL7609367

SCHEMBL7609367

[CH2]CC(N)S(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4259508 0.78
SCHEMBL3764202 0.74
SCHEMBL4722404 0.73
SCHEMBL5560354 0.73
SCHEMBL7412312 0.71
SCHEMBL8500628 0.71
SCHEMBL28872871 0.69
SCHEMBL8005394 0.69
SCHEMBL4795798 0.69 TP53 (0.38)
SCHEMBL5897323 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1476446-A Benzodiazepine derivative ֮����ʽ���� 2004-02-18 CN claimed
CN-103221405-A Substituted pyridine compound DAIICHI SANKYO CO LTD 2013-07-24 CN disclosed
CN-101384532-B method for producing optically active alcohol KOTOBUKI PHARMACEUTICAL CO LTD 2013-01-02 CN disclosed
CN-102753522-A Substituted pyrrolidine-2-carboxamides HOFFMANN LA ROCHE 2012-10-24 CN disclosed
CN-102159207-A Substituted pyrrolidine-2-carboxamides HOFFMANN LA ROCHE 2011-08-17 CN disclosed
CN-101663303-A Heteroaromatics, its preparation method with and uses thereof SUN PIAOYANG 2010-03-03 CN disclosed
CN-101384532-A Method for producing optically active alcohol KOTOBUKI PHARMACEUTICAL CO LTD (JP) 2009-03-11 CN disclosed
CN-1476446-A Benzodiazepine derivative ֮����ʽ���� 2004-02-18 CN disclosed
EP-1230210-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-08-14 EP disclosed
WO-2001036375-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-25 WO disclosed